On the Extropians list, Dennis Ivey suggested Abiomed as a candidate for
extropic socially responsible investments.
Since then, I came across this bearish article on Abiomed by Herb Green of
The Street. Green is notoriously bearish, but is sometimes right (even when
I don't like it, as with LHSP). He warns about the high risk of Abiomed at
current prices:
http://moneycentral.msn.com/articles/common/greenberg.asp
I haven't examined this market, so I'm not taking a position, just
submitting this for your information.
Onward!
Max
_______________________________________________________
Max More, Ph.D.
max@maxmore.com or more@extropy.org
www.maxmore.com
President, Extropy Institute. www.extropy.org
Senior Content Architect, ManyWorlds Inc.: www.manyworlds.com
_______________________________________________________
This archive was generated by hypermail 2b30 : Mon May 28 2001 - 09:56:47 MDT